Purchase Order 75N93020P01156
Award Date 8/26/20
Potential Completion Date 8/19/21
Potential Value $249K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Royal Oak, MI 48073, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...
- This is a $37,000 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Protein Sciences Corp, a for-profit manufacturer, to provide purified recombinant proteins. The contract has no set-aside designation. Protein Sciences Corp has received multiple federal contract awards from HHS's Office of the Assistant Secretary for Preparedness and Response...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $150,355.40 firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for COVID-19 research services. The contract includes DNA synthesis, cloning, plasmid preparation, and antibody expression and purification to support the Vaccine Research Center's continued COVID-19 studies. The services are to be performed at the NIH facility...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide protein antigen production for coronavirus vaccine antigens in support of COVID-19 research. The $139,989.48 contract has a completion date of September 23, 2022. Genscript has previously received federal awards from agencies such as the USDA to...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Boston Bioscience Inc. for $13,150.00 on August 30, 2017. The order procures Ebola peptides, seven residues. Work is performed in Royal Oak, Michigan. The order has an ultimate completion date of August 29, 2018.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,540.94 firm fixed price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for DNA synthesis services. This sole-source award supports the Vaccine Research Center's efforts to develop vaccine and passive immunotherapy candidates, including monoclonal antibodies, for biodefense-related pathogens such as Ebola and Lassa...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $496,069.49 Firm Fixed Price delivery order to Government Scientific Source Inc., a for-profit organization, for the purchase of a BIACORE 8K+ INSTRUMENT KIT to support COVID-19 research and testing. This requirement was not set aside for small businesses. The award was placed under the Multiple Award Schedule (MAS) contract vehicle. Government Scientific...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $23,380.00 firm fixed price purchase order to Research And Diagnostic Systems, Inc. (R&D Systems), a small business manufacturer of research reagents and instruments. The contract is for the delivery of recombinant proteins, which are likely to support NIAID's biomedical research and investigation efforts, including potential COVID-19-related...
- This federal contract award to Protein Sciences Corp, a for-profit manufacturer, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS). The $14,675 firm-fixed-price purchase order is for the provision of tested influenza virus proteins. The contract does not have a set-aside designation. Protein Sciences has received multiple previous federal contract awards from the HHS Office of the Assistant Secretary...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $576,000 firm fixed price purchase order to Nova Biomedical Corporation of Waltham, Massachusetts. The contract calls for COVID-19 related equipment including five BioProfile FLEX2 modules to support the agency's coronavirus response efforts. Performance will occur in Waltham through July 2020. No set aside designation or subcontractors were indicated. This...